The Pharmaceutical Regulatory Affairs in China 2025 is a course dedicated to the key areas of pharmaceutical regulatory affairs in China, Hong Kong, Macau and Taiwan.
Topics
- An overview of import and local manufacture registration
- Drug regulatory systems
- An interpretation of practical aspects
- Clinical product development including CMC regulatory requirements
- The opportunity to exchange experiences with other delegates
- Recent developments
Who should Attend
- Personnel from the following areas
- Clinical Development
- Analytical Research and Development
- New Business Development
- Quality Assurance
- Regulatory Authorities
- QScientists and Technical staff in
- Registration Departments
- Regulatory Affairs
- Medical Directors
